Death Rate Lower for Hispanic Men With Advanced Prostate Cancer
Among men with Medicare coverage, Hispanic men had a significant 37% decreased risk for death compared with both non-Hispanic White men and Black men, a study found.
All articles by Jody Charnow
Earlier Surrogate for Survival After RP Relapse Possibly Identified
Castration-resistant prostate cancer correlates strongly with development of metastasis in men with PSA relapse following radical surgery for localized prostate cancer, but it occurs much sooner, and thus may provide an intermediate endpoint in clinical trials of new therapeutics.
HIFU Focal Ablation for PCa Offers Adequate Short-Term Cancer Control
In a study, men who underwent high-intensity focused ultrasound partial gland ablation for prostate cancer had excellent preservation of potency and continence.
Carboplatin Possibly Beneficial in Refractory mCRPC
In a retrospective study, addition of carboplatin to chemotherapy regimens improved survival in men with metastatic castration-resistant prostate cancer whose disease progressed on second-generation hormone therapy.
Radiation Therapy After Prostate Surgery Offers No Benefit
Study findings suggest that many men can be spared radiation therapy following radical prostatectomy for high-risk prostate cancer.
Upfront Antiandrogens, Chemotherapy for mCRPC Offer Similar Survival
Men who receive first-line abiraterone or enzalutamide or first-line docetaxel treatment for metastatic castration-resistant prostate cancer have similar overall survival, a prospective, observational cohort study found.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...